Cargando…

434 Prevalence, Risk Factors, and Outcomes of Bacteremia Caused by Carbapenem-resistant Enterobacteriaceae in Neutropenic Patients with Hematologic Malignancies

Detalles Bibliográficos
Autores principales:	Satlin, Michael J., Cohen, Nina, Ma, Kevin C., Gedrimaite, Zivile, Walsh, Thomas J., Seo, Susan K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	IDWeek 2014 Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781763/ http://dx.doi.org/10.1093/ofid/ofu052.300

Ejemplares similares

959 Epidemiology and Treatment of Enterobacteriaceae Bacteremia: Combination vs Monotherapy
por: Berkowitz, Nina, et al.
Publicado: (2014)

369 Outcomes of Patients with Carbapenem-Resistant Enterobacteriaceae
por: Raybould, Jillian, et al.
Publicado: (2014)

354 Six Months of Surveillance for Carbapenem-Resistant Enterobacteriaceae in Maryland
por: Vaeth, Elisabeth, et al.
Publicado: (2014)

359 Epidemiology of Carbapenem-Resistant Enterobacteriaceae (CRE) at an Academic Medical Center
por: Leiner, Charles, et al.
Publicado: (2014)

1800 Phenotypic Definitions for Identifying Carbapenemase-Producing Carbapenem-resistant Enterobacteriaceae
por: Chea, Nora, et al.
Publicado: (2014)

720 Clinical Features and Risk Factors for Mortality of Stenotrophomonas maltophilia Bacteremia in Patients with Hematologic Malignancies
por: Cho, Sun Young, et al.
Publicado: (2014)

364 Utility of Carbapenem-Resistant Enterobacteriaceae Surveillance Cultures in Predicting Clearance of Colonization
por: Lewis, Jessica, et al.
Publicado: (2014)

356 Epidemiology of Community-Associated Carbapenem-Resistant Enterobacteriaceae Identified through the Emerging Infections Program
por: Bulens, Sandra, et al.
Publicado: (2014)

355 Carbapenem-Resistant Enterobacteriaceae (CRE) Distribution within the Veterans Affairs Healthcare System: 2013
por: Ryono, Russell, et al.
Publicado: (2014)

479 Clinical outcomes in patients with extended-spectrum-beta-lactamase-producing (ESBL) Enterobacteriaceae bloodstream infections (ESB) treated with carbapenems (CP) and non-carbapenems (NC)
por: Chin, Judy, et al.
Publicado: (2014)

1675 A Novel Murine Pneumonia and Bacteremia Model for Carbapenem-Resistant Klebsiella pneumoniae Infection
por: Kavanaugh, Michael, et al.
Publicado: (2014)

1726 What Defines Carbapenem-Resistant Enterobacteriaceae (CRE) in a Low Prevalence State? Oregon, 2010 — 2013
por: Maureen Cassidy, P., et al.
Publicado: (2014)

716 Risk Factors for Resistance to Beta-lactam/Beta-lactamase Inhibitors and Carbapenems in Bacteroides spp. Bacteremia
por: Smith, Janessa, et al.
Publicado: (2014)

466 Skin lesions in febrile neutropenic patients
por: Yemisen, Mucahit, et al.
Publicado: (2014)

331 Risk Factors for Vancomycin-resistant Enterococci and Carbapenemase-producing Carbapenem-resistant Enterobacteriaceae Colonization at admission to a Tertiary-care Center
por: Chow, Angela, et al.
Publicado: (2014)

257 In Vitro Activity of Meropenem/RPX7009, a Carbapenem/β-lactamase Inhibitor Combination Tested Against Contemporary Populations of Enterobacteriaceae and KPC-producing Strains
por: Castanheira, Mariana, et al.
Publicado: (2014)

1119 Respiratory Viral Infections in a Cohort of Patients with Hematological Malignancies
por: Vilar-Compte, Diana, et al.
Publicado: (2014)

1466 Primary Cutaneous Mold Infections in Hematologic Malignancy with a Review of the Literature
por: Mai, Jane, et al.
Publicado: (2014)

1463 Immune Reconstitution Inflammatory Syndrome (IRIS) in Neutropenic Patients with Invasive Pulmonary Aspergillosis (IPA) during Neutrophil Recovery
por: Jung, Jiwon, et al.
Publicado: (2014)

672 Staphylococcus aureus Bacteremia in Hospitalized Children
por: Klieger, Sarah B., et al.
Publicado: (2014)

418 Antimicrobial Profile of Enterobacteriaceae from North America from 2013
por: Johnson, Brian, et al.
Publicado: (2014)

277 Molecular Epidemiology of Staphyloccocus aureus in Children with Bacteremia
por: Al-Zubeidi, Duha, et al.
Publicado: (2014)

726 Readmission rate associated with Staphylococcus aureus bacteremia
por: Lee, Jean, et al.
Publicado: (2014)

424 Characterization and Profiling of Multi-Drug Resistant (MDR) Enterobacteriaceae From Latin America
por: Renteria, Martha, et al.
Publicado: (2014)

253 Activity of Eravacycline Against Enterobacteriaceae and Acinetobacter baumannii from New York City
por: Abdallah, Marie, et al.
Publicado: (2014)

249 Activity of Plazomicin Against Contemporary Isolates of Enterobacteriaceae from New York City
por: Olafisoye, Olawole, et al.
Publicado: (2014)

135 Fosfomycin Susceptibilities Among Uropathogenic Extended Spectrum Beta-Lactamase-producing Enterobacteriacea
por: Abbo, Lilian, et al.
Publicado: (2014)

734 Pneumococcal Bacteremia in Cancer Patients: A Case Series
por: Acevedo, Ileana, et al.
Publicado: (2014)

High risk of bloodstream infection of carbapenem-resistant enterobacteriaceae carriers in neutropenic children with hematological diseases
por: Liu, Li-Peng, et al.
Publicado: (2023)

133 Compliance with follow-up cultures in Staphylococcus aureus bacteremia: Opportunity for quality improvement
por: Thomas, Benjamin S., et al.
Publicado: (2014)

260 Ceftolozane/Tazobactam for the Treatment of cUTI and cIAI Caused by ESBL-producing Enterobacteriaceae
por: Popejoy, Myra, et al.
Publicado: (2014)

261 Comparative in vitro Activity of Sitafloxacin and Other Antibiotics Against Clinical Isolates of Carbapenem-Resistant Acinetobacter baumannii and Carbapenem-Resistant Pseudomonas aeruginosa by Disk Diffusion Method
por: Linasmita, Patcharasarn, et al.
Publicado: (2014)

474 Ceftaroline Salvage Therapy for MRSA Bacteremia Following Vancomycin Failure
por: Pettit, Natasha, et al.
Publicado: (2014)

714 Gram Negative Bacteremia: Are Shorter Courses of Antimicrobial Therapy Feasible?
por: Swamy, Siddharth, et al.
Publicado: (2014)

731 Utility of Ceftaroline in the Treatment of Persistent Bacteremia and Deep-Seated Infections
por: Burgess, Donna R., et al.
Publicado: (2014)

487 Infections Caused by Enterobacteriaceae Species following Cardiac Surgery: Impact of Polymyxin Resistance on Treatment Outcomes
por: Abboud, Cely Saad, et al.
Publicado: (2014)

134 Implement of a Mandatory Infectious Disease Consultation for Staphylococcus aureus Bacteremia
por: Salazar, Diana, et al.
Publicado: (2014)

169 Rapid Testing using Verigene® Microarray in Combination with Antimicrobial Stewardship Intervention in Gram-negative Bacteremia
por: Bork, Jacqueline T., et al.
Publicado: (2014)

735 Nutritionally Variant Streptococci Bacteremia in Cancer Patients: A Relatively Benign Occurrence
por: Acevedo, Ileana, et al.
Publicado: (2014)

727 Evaluating the Impact of Socioeconomic Status on Clinical Presentation in Patients with Staphylococcus aureus Bacteremia
por: Clemenzi-Allen, Angelo, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_vc9r4sk9o32nskedfjnaifnub0